14 Nov 2025 | 3 Mins Read
Natco Pharma Reports Q2 Earnings Decline
Flipitmoney
Natco Pharma reported a 23.5% y-o-y decline in net profit at ₹518 crore, a ₹28% drop in EBITDA to ₹579 crore and narrowed EBITDA margin to 42.5%. Revenue dipped to ₹1,363 crore from ₹1,371 crore last year. The company declared an interim dividend of ₹1.50 per equity share. Shares declined 2% to ₹810.